Improving the Prognosis for Patients with BRAF-mutant and/or MSI-H mCRC

Case Study

Are you current with the latest updates with MSI-H/dMMR and/or BRAF-mutant metastatic colorectal cancer? In this case-based activity, leading expert and researcher, Dr. Dung Le discusses the latest approvals and recommendations for patients with MSI-H/dMMR and/or BRAF-mutant mCRC. This activity also features interactive case presentations which involve biomarker testing, treatment selection, and mitigating potential adverse events.

Faculty: Dung Le, MD

Release Date: October 25, 2021

Expiration Date: October 25, 2022

CME/CE is no longer available for this activity